Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease
NCT ID: NCT00841464
Last Updated: 2012-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2009-03-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants with Parkinson's disease will be recruited at the PADRECC of the Philadelphia VA Medical Center. Enrolled participants will be randomly assigned to receive either active external magnetic stimulation or fake stimulation. The external magnetic stimulation is delivered by wearing a helmet that is embedded with many small circuits which produce a very small magnetic field around the head. The helmet is to be worn daily for two minutes immediately before bedtime for three months in a row. The helmet is for investigational use only and has not been approved for use by the FDA.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of possible or probable PD by the UK Brain Bank clinical diagnostic criteria
* Stable anti-Parkinsonian medical regimen for at least 30 days prior to enrollment
* Hoehn \& Yahr Scale score of I to III
* No evidence of secondary or atypical Parkinsonism on MRI test in the past year
* Subjects are capable of giving informed consent
Exclusion Criteria
* History of stroke or TIA within the past year
* Dementia defined as a MMSE score \< 25
* Status post deep brain stimulation surgery
* Unstable medical conditions that would likely prevent the subject from completing the study
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Philadelphia
OTHER
Parkinson's Disease Research, Education, and Clinical Center, Philadelphia
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John E Duda, M.D.
Role: PRINCIPAL_INVESTIGATOR
Parkinson's Disease Research, Education, and Clinical Center (PADRECC), Philadelphia
Timothy Roberts, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Radiology, The Children's Hospital of Philadelphia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Philadelphia VA Medical Center
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1EA-0000071
Identifier Type: -
Identifier Source: org_study_id